Brain repair trial tests common allergy drug for MS
NCT ID NCT06065670
Summary
This study is testing if an existing allergy medication, clemastine fumarate, can help repair the protective coating (myelin) around nerves in the brain for people with multiple sclerosis (MS). It will involve 44 adults with MS who have recently active brain lesions. Researchers will use advanced MRI scans to see if the drug helps regrow myelin over 6 months, compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS BRAIN LESION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sandler Neurosciences Building, Neurological Clinical Research Unit
San Francisco, California, 94107, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.